HANALL BIOPHARMA CO., LTD. is a Korea-based company engaged in manufacture and marketing of biopharmaceuticals. The Company principally produces antidiabetic drugs, skin drugs, muscle relaxants, hepatitis drugs, digestion drugs, anti-cardiovascular drugs, neurologic drugs, interferons, antiviral drugs, antibiotics, antihistamine, anti-inflammatory drugs, respiratory drugs and others. The Company also produces nutrients, infusions used for cosmetic surgeries and others. In addition, the Company engages in the leasing business. As of December 31, 2011, the Company had two subsidiaries, HPI,INC. and HANALL NAUTILUS BIOTECH.